miRview™ meso accurately differentiates malignant pleural mesothelioma from other carcinomas in the lung and pleura
Many cancer diagnostics are associated with significant challenges, including suboptimal sensitivity and specificity
1 and low concordance levels
2. Unlike the tests currently available, miRview™ meso is a microRNA-based molecular diagnostic tool that provides a differential diagnosis with:
- Accuracy
- Simple interpretation
- Routine sample preparation
miRview™ meso delivers quality results
The miRview™ meso assay uses quantitative real-time PCR (qRT-PCR) to determine the expression of microRNA in tumor tissue. The sensitivity and specificity of this assay have been shown to be 100% and 94%, respectively
3.
miRview™ meso is easy to use
miRview™ meso is based on formalin-fixed paraffin-embedded (FFPE) tumor samples, the current standard for preserving tumors in the post-op setting. FFPE samples require minimal preparation to be analyzed by our experts and can be easily shipped via any air courier.
- Rosenfeld N, Aharonov R, Meiri E, et al. MicroRNAs accurately identify cancer tissue origin.
Nat Biotechnol. 2008;26(4):462-469.
- Stang A, Pohlabeln H, M?ller KM, Jahn I, Giersiepen K, J?ckel KH. Diagnostic agreement in the histopathological evaluation of lung cancer tissue in a population-based case-control study. Lung Cancer. 2006;52(1):29-36.
- Data on file, Rosetta Genomics.
